Gene Symbol | Gene ID | Gene Info |
---|---|---|
Obox6
|
ENSMUSG00000041583.7 | oocyte specific homeobox 6 |
Obox5
|
ENSMUSG00000074366.3 | oocyte specific homeobox 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_15835107_15835258 | Obox6 | 4496 | 0.127888 | -0.10 | 4.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_54957303_54957776 | 7.22 |
Gm45263 |
predicted gene 45263 |
2280 |
0.24 |
chr9_4794566_4795419 | 7.09 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
527 |
0.88 |
chr2_94246278_94247531 | 6.17 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3566 |
0.17 |
chr16_77598670_77599917 | 5.78 |
Mir99a |
microRNA 99a |
357 |
0.44 |
chr7_144132849_144134003 | 5.75 |
Gm44999 |
predicted gene 44999 |
22341 |
0.2 |
chr12_35896354_35896707 | 5.69 |
Agr3 |
anterior gradient 3 |
29090 |
0.17 |
chr13_109928298_109928867 | 5.39 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1738 |
0.46 |
chr9_41585078_41585353 | 5.36 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2554 |
0.15 |
chr1_143640264_143641520 | 5.36 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr6_28828230_28829085 | 5.36 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr3_141466933_141467846 | 5.35 |
Unc5c |
unc-5 netrin receptor C |
1718 |
0.37 |
chr14_66344363_66345813 | 5.32 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chrX_166346283_166346827 | 5.29 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr16_77645925_77646470 | 5.29 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr14_39471112_39471496 | 5.23 |
Nrg3 |
neuregulin 3 |
1362 |
0.61 |
chr15_40533600_40534035 | 5.17 |
Gm7382 |
predicted gene 7382 |
3504 |
0.28 |
chr15_48791303_48792616 | 5.15 |
Csmd3 |
CUB and Sushi multiple domains 3 |
26 |
0.99 |
chrX_165326400_165326667 | 5.14 |
Glra2 |
glycine receptor, alpha 2 subunit |
860 |
0.76 |
chr18_34249368_34249586 | 4.99 |
Apc |
APC, WNT signaling pathway regulator |
1779 |
0.35 |
chr17_48932346_48933546 | 4.90 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
567 |
0.85 |
chr18_35213481_35213842 | 4.89 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1269 |
0.34 |
chr7_60449424_60450258 | 4.89 |
Gm30196 |
predicted gene, 30196 |
156637 |
0.03 |
chr8_8655111_8656501 | 4.84 |
Efnb2 |
ephrin B2 |
5433 |
0.1 |
chr16_5884597_5886147 | 4.79 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr5_126768981_126769769 | 4.76 |
Gm33347 |
predicted gene, 33347 |
42091 |
0.14 |
chr3_17793835_17795104 | 4.72 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr17_56241459_56242409 | 4.63 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
218 |
0.81 |
chr2_6883618_6884699 | 4.61 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr5_7342376_7342862 | 4.59 |
Zfp804b |
zinc finger protein 804B |
2137 |
0.32 |
chr7_16921141_16922156 | 4.57 |
Calm3 |
calmodulin 3 |
2181 |
0.15 |
chr13_58809397_58810364 | 4.50 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
1189 |
0.34 |
chr2_55437909_55438060 | 4.48 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
819 |
0.72 |
chr4_102588865_102590254 | 4.48 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
164 |
0.97 |
chr6_13835523_13837039 | 4.45 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr9_75681964_75682559 | 4.38 |
Scg3 |
secretogranin III |
1326 |
0.37 |
chr2_22626293_22626566 | 4.35 |
Gad2 |
glutamic acid decarboxylase 2 |
3125 |
0.18 |
chr4_9270926_9271667 | 4.35 |
Clvs1 |
clavesin 1 |
159 |
0.96 |
chr1_154725377_154725528 | 4.34 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
468 |
0.89 |
chr18_31445092_31445474 | 4.32 |
Syt4 |
synaptotagmin IV |
2123 |
0.26 |
chr8_112570000_112570856 | 4.31 |
Cntnap4 |
contactin associated protein-like 4 |
373 |
0.76 |
chr8_41052368_41053980 | 4.28 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr13_71960720_71961584 | 4.26 |
Irx1 |
Iroquois homeobox 1 |
436 |
0.87 |
chr5_131531462_131532675 | 4.24 |
Auts2 |
autism susceptibility candidate 2 |
2329 |
0.29 |
chr1_194621304_194621650 | 4.22 |
Plxna2 |
plexin A2 |
1652 |
0.38 |
chr3_67892003_67892637 | 4.20 |
Iqschfp |
Iqcj and Schip1 fusion protein |
88 |
0.51 |
chr18_77564268_77564635 | 4.20 |
Rnf165 |
ring finger protein 165 |
158 |
0.96 |
chr13_20473087_20474265 | 4.09 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr5_84414084_84414723 | 4.05 |
Epha5 |
Eph receptor A5 |
2403 |
0.37 |
chr18_25752531_25753655 | 4.04 |
Celf4 |
CUGBP, Elav-like family member 4 |
401 |
0.88 |
chr4_140245362_140247262 | 4.04 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr17_80946268_80946852 | 4.01 |
Tmem178 |
transmembrane protein 178 |
1928 |
0.35 |
chr3_84953332_84953942 | 3.87 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
1491 |
0.53 |
chr12_29537800_29538885 | 3.85 |
Myt1l |
myelin transcription factor 1-like |
3120 |
0.28 |
chr13_83727321_83728283 | 3.84 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
304 |
0.83 |
chr11_17051649_17052968 | 3.83 |
Plek |
pleckstrin |
73 |
0.88 |
chr15_25753741_25754105 | 3.82 |
Myo10 |
myosin X |
944 |
0.64 |
chr1_109986155_109986359 | 3.79 |
Cdh7 |
cadherin 7, type 2 |
2520 |
0.44 |
chr7_10480473_10481196 | 3.77 |
Gm30645 |
predicted gene, 30645 |
11141 |
0.11 |
chr18_25751839_25752425 | 3.77 |
Celf4 |
CUGBP, Elav-like family member 4 |
560 |
0.81 |
chr5_113490881_113491656 | 3.73 |
Wscd2 |
WSC domain containing 2 |
516 |
0.83 |
chr18_57785762_57786717 | 3.72 |
Gm19519 |
predicted gene, 19519 |
6094 |
0.27 |
chr3_17792584_17792950 | 3.72 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1153 |
0.46 |
chr3_84219870_84221146 | 3.71 |
Trim2 |
tripartite motif-containing 2 |
337 |
0.91 |
chr11_84517379_84517961 | 3.67 |
Aatf |
apoptosis antagonizing transcription factor |
4148 |
0.21 |
chr1_140661037_140661562 | 3.66 |
4930590L20Rik |
RIKEN cDNA 4930590L20 gene |
4895 |
0.34 |
chr16_11985754_11986188 | 3.66 |
Shisa9 |
shisa family member 9 |
1251 |
0.58 |
chr12_29529828_29531185 | 3.65 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chrX_165326738_165328112 | 3.63 |
Glra2 |
glycine receptor, alpha 2 subunit |
32 |
0.99 |
chr11_93098807_93100169 | 3.63 |
Car10 |
carbonic anhydrase 10 |
198 |
0.97 |
chr10_62863746_62864710 | 3.62 |
Tet1 |
tet methylcytosine dioxygenase 1 |
1076 |
0.37 |
chr2_116068937_116070512 | 3.61 |
G630016G05Rik |
RIKEN cDNA G630016G05 gene |
1756 |
0.28 |
chr2_16358886_16359826 | 3.59 |
Plxdc2 |
plexin domain containing 2 |
2239 |
0.48 |
chr7_99383478_99385192 | 3.58 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
1563 |
0.33 |
chr14_64591036_64591686 | 3.58 |
Mir3078 |
microRNA 3078 |
176 |
0.84 |
chr1_193369065_193370282 | 3.58 |
Camk1g |
calcium/calmodulin-dependent protein kinase I gamma |
552 |
0.7 |
chr16_63857163_63857952 | 3.58 |
Epha3 |
Eph receptor A3 |
5856 |
0.31 |
chr8_31915784_31916390 | 3.57 |
Nrg1 |
neuregulin 1 |
1563 |
0.42 |
chr15_23037371_23038142 | 3.46 |
Cdh18 |
cadherin 18 |
1293 |
0.6 |
chr1_135372451_135373569 | 3.44 |
Shisa4 |
shisa family member 4 |
440 |
0.74 |
chr8_17532221_17533470 | 3.44 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr1_81077232_81078427 | 3.42 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr7_3332929_3333897 | 3.42 |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
458 |
0.64 |
chr9_52678302_52679671 | 3.41 |
AI593442 |
expressed sequence AI593442 |
443 |
0.69 |
chr8_109248831_109249717 | 3.40 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr18_13305534_13306224 | 3.39 |
Gm41669 |
predicted gene, 41669 |
459 |
0.87 |
chr5_74676974_74677904 | 3.39 |
Lnx1 |
ligand of numb-protein X 1 |
190 |
0.94 |
chr13_28416755_28419194 | 3.38 |
Gm40841 |
predicted gene, 40841 |
1889 |
0.42 |
chr15_92598307_92599654 | 3.37 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr2_73659027_73659663 | 3.37 |
Chn1 |
chimerin 1 |
1031 |
0.37 |
chr15_25417810_25418559 | 3.37 |
Gm48957 |
predicted gene, 48957 |
3121 |
0.19 |
chr6_93911862_93913573 | 3.37 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr13_83735558_83735982 | 3.37 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chr3_38892303_38893788 | 3.36 |
Fat4 |
FAT atypical cadherin 4 |
2103 |
0.36 |
chr4_22485441_22485749 | 3.36 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
2771 |
0.23 |
chr6_13837266_13838183 | 3.36 |
Gpr85 |
G protein-coupled receptor 85 |
483 |
0.82 |
chr11_101176105_101177957 | 3.35 |
Cntnap1 |
contactin associated protein-like 1 |
990 |
0.28 |
chr3_79144294_79146166 | 3.30 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr10_90576163_90577493 | 3.27 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr2_4017802_4019015 | 3.27 |
Frmd4a |
FERM domain containing 4A |
664 |
0.68 |
chr3_60530332_60531570 | 3.27 |
Mbnl1 |
muscleblind like splicing factor 1 |
1320 |
0.48 |
chr2_62341681_62342220 | 3.27 |
Dpp4 |
dipeptidylpeptidase 4 |
3196 |
0.24 |
chrX_103184543_103184694 | 3.26 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
2022 |
0.23 |
chr11_94045498_94046076 | 3.26 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr2_57698968_57699458 | 3.23 |
Gm25388 |
predicted gene, 25388 |
45391 |
0.15 |
chr8_45507516_45508498 | 3.23 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr15_84260540_84260897 | 3.22 |
Parvb |
parvin, beta |
3578 |
0.2 |
chr13_14521332_14521483 | 3.22 |
Gm30893 |
predicted gene, 30893 |
79 |
0.63 |
chr10_116020427_116020646 | 3.22 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
2249 |
0.41 |
chr7_112681736_112682136 | 3.21 |
2310014F06Rik |
RIKEN cDNA 2310014F06 gene |
1855 |
0.27 |
chr15_91017138_91018295 | 3.21 |
Kif21a |
kinesin family member 21A |
32102 |
0.16 |
chr4_5724213_5725550 | 3.20 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr3_88206822_88208169 | 3.20 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr9_117870768_117871285 | 3.19 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
1558 |
0.39 |
chr3_17790150_17790808 | 3.16 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
522 |
0.77 |
chr10_104456207_104456415 | 3.15 |
Gm22945 |
predicted gene, 22945 |
14896 |
0.27 |
chr3_68573207_68574269 | 3.15 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr2_152083384_152083946 | 3.14 |
Scrt2 |
scratch family zinc finger 2 |
2136 |
0.23 |
chr13_84061710_84062414 | 3.13 |
Gm17750 |
predicted gene, 17750 |
2710 |
0.31 |
chr8_45509543_45510137 | 3.13 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
1922 |
0.33 |
chr6_110646867_110647408 | 3.12 |
Gm20387 |
predicted gene 20387 |
1221 |
0.44 |
chr5_116589538_116590511 | 3.12 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr1_25832036_25832712 | 3.11 |
Gm9884 |
predicted gene 9884 |
1717 |
0.22 |
chr2_65620767_65621991 | 3.10 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr6_104492794_104494036 | 3.09 |
Cntn6 |
contactin 6 |
167 |
0.98 |
chr4_25797148_25797299 | 3.09 |
Fut9 |
fucosyltransferase 9 |
2632 |
0.27 |
chr13_44842150_44842855 | 3.07 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr2_105670737_105671693 | 3.07 |
Pax6 |
paired box 6 |
645 |
0.51 |
chr8_122750756_122751439 | 3.07 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
1228 |
0.3 |
chr1_66321652_66322390 | 3.07 |
Map2 |
microtubule-associated protein 2 |
23 |
0.98 |
chr8_47333763_47334279 | 3.07 |
Stox2 |
storkhead box 2 |
18327 |
0.23 |
chr9_110051810_110053856 | 3.06 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr5_142812883_142813172 | 3.05 |
Tnrc18 |
trinucleotide repeat containing 18 |
4353 |
0.21 |
chr5_112227269_112228017 | 3.05 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
998 |
0.41 |
chr11_34314782_34314986 | 3.05 |
Insyn2b |
inhibitory synaptic factor family member 2B |
62 |
0.97 |
chr17_66446136_66446287 | 3.02 |
Mtcl1 |
microtubule crosslinking factor 1 |
2158 |
0.25 |
chr19_37172561_37172787 | 3.02 |
A330032B11Rik |
RIKEN cDNA A330032B11 gene |
1169 |
0.32 |
chr6_8414167_8414463 | 3.00 |
Umad1 |
UMAP1-MVP12 associated (UMA) domain containing 1 |
5363 |
0.18 |
chr7_87586513_87587584 | 3.00 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chrX_147552308_147552607 | 2.99 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1593 |
0.47 |
chr7_16174775_16175246 | 2.98 |
Meis3 |
Meis homeobox 3 |
80 |
0.95 |
chr6_6861689_6861840 | 2.98 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
173 |
0.9 |
chr4_150284018_150284403 | 2.97 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
2398 |
0.24 |
chr4_105108487_105108685 | 2.97 |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
1304 |
0.56 |
chr14_39472202_39472383 | 2.96 |
Nrg3 |
neuregulin 3 |
374 |
0.93 |
chr13_28949369_28949858 | 2.94 |
Sox4 |
SRY (sex determining region Y)-box 4 |
4100 |
0.25 |
chr1_23764777_23765091 | 2.94 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
2923 |
0.36 |
chr10_18408068_18409081 | 2.93 |
Nhsl1 |
NHS-like 1 |
899 |
0.67 |
chr16_72027587_72029370 | 2.93 |
Gm49667 |
predicted gene, 49667 |
149434 |
0.04 |
chr3_97763340_97765161 | 2.93 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
3681 |
0.23 |
chr9_113814888_113815428 | 2.93 |
Clasp2 |
CLIP associating protein 2 |
2558 |
0.32 |
chr1_160350716_160351791 | 2.91 |
Rabgap1l |
RAB GTPase activating protein 1-like |
318 |
0.88 |
chr6_45062685_45062917 | 2.91 |
Cntnap2 |
contactin associated protein-like 2 |
2740 |
0.24 |
chr9_96731522_96733329 | 2.90 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chrX_43427105_43427755 | 2.90 |
Tenm1 |
teneurin transmembrane protein 1 |
1573 |
0.42 |
chr2_72529242_72530181 | 2.87 |
Rps13-ps8 |
ribosmal protein S13, pseudogene 8 |
15501 |
0.19 |
chr6_136172206_136173574 | 2.86 |
Gm26653 |
predicted gene, 26653 |
171 |
0.59 |
chr3_8663653_8664237 | 2.86 |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
2680 |
0.2 |
chr17_66235333_66235831 | 2.85 |
Gm49932 |
predicted gene, 49932 |
637 |
0.64 |
chr8_12915306_12916734 | 2.85 |
Mcf2l |
mcf.2 transforming sequence-like |
45 |
0.76 |
chr7_61981610_61982350 | 2.85 |
A330076H08Rik |
RIKEN cDNA A330076H08 gene |
323 |
0.52 |
chr1_41604694_41605241 | 2.85 |
Gm28634 |
predicted gene 28634 |
75424 |
0.12 |
chrX_143518219_143519318 | 2.84 |
Pak3 |
p21 (RAC1) activated kinase 3 |
70 |
0.98 |
chr15_71727296_71727625 | 2.84 |
Fam135b |
family with sequence similarity 135, member B |
378 |
0.89 |
chr1_133183797_133183948 | 2.82 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
2551 |
0.26 |
chr5_65132296_65132503 | 2.82 |
Klhl5 |
kelch-like 5 |
728 |
0.62 |
chr2_62046631_62048214 | 2.82 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
777 |
0.76 |
chrX_84078164_84078482 | 2.82 |
Dmd |
dystrophin, muscular dystrophy |
1674 |
0.47 |
chr10_90578974_90579573 | 2.82 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
2281 |
0.42 |
chr2_82056608_82056868 | 2.82 |
Zfp804a |
zinc finger protein 804A |
3516 |
0.36 |
chr11_34315414_34316667 | 2.81 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr4_97582473_97584218 | 2.80 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1251 |
0.53 |
chr10_101681584_101682324 | 2.80 |
Mgat4c |
MGAT4 family, member C |
208 |
0.96 |
chr15_44747728_44748502 | 2.79 |
Sybu |
syntabulin (syntaxin-interacting) |
198 |
0.95 |
chr6_145047358_145048434 | 2.79 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
43 |
0.82 |
chr8_125997145_125997778 | 2.78 |
Kcnk1 |
potassium channel, subfamily K, member 1 |
2025 |
0.35 |
chr8_41054476_41055299 | 2.76 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr13_84063384_84064052 | 2.76 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr2_28195247_28196182 | 2.76 |
Olfm1 |
olfactomedin 1 |
2621 |
0.32 |
chr15_78915623_78916717 | 2.74 |
Pdxp |
pyridoxal (pyridoxine, vitamin B6) phosphatase |
2251 |
0.12 |
chr7_60047230_60047526 | 2.74 |
Snrpn |
small nuclear ribonucleoprotein N |
42267 |
0.06 |
chrX_134295383_134296942 | 2.73 |
Tmem35a |
transmembrane protein 35A |
937 |
0.52 |
chr5_144547334_144548656 | 2.72 |
Nptx2 |
neuronal pentraxin 2 |
2093 |
0.41 |
chr2_158606690_158608449 | 2.72 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr5_111424407_111425623 | 2.71 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr11_109297097_109298424 | 2.71 |
Rgs9 |
regulator of G-protein signaling 9 |
306 |
0.9 |
chr18_15390886_15391037 | 2.70 |
Aqp4 |
aquaporin 4 |
9041 |
0.2 |
chr3_54154932_54155429 | 2.70 |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
855 |
0.72 |
chr13_58811544_58811751 | 2.68 |
C630044B11Rik |
RIKEN cDNA C630044B11 gene |
506 |
0.69 |
chr3_34197711_34199105 | 2.68 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1544 |
0.41 |
chr5_128596612_128597857 | 2.68 |
Gm42498 |
predicted gene 42498 |
722 |
0.6 |
chr14_93886537_93886688 | 2.66 |
Pcdh9 |
protocadherin 9 |
388 |
0.91 |
chr7_46399823_46400899 | 2.65 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
2713 |
0.23 |
chr13_48264468_48265300 | 2.63 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
2261 |
0.19 |
chr6_93911298_93911653 | 2.62 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
1029 |
0.62 |
chr3_89521563_89522618 | 2.62 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
1926 |
0.28 |
chr7_92234907_92236280 | 2.62 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr18_22346733_22347750 | 2.62 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
2152 |
0.48 |
chr9_40268795_40270233 | 2.61 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
81 |
0.96 |
chr10_96619654_96620334 | 2.61 |
Btg1 |
BTG anti-proliferation factor 1 |
2440 |
0.31 |
chr1_92849002_92850443 | 2.61 |
Mir149 |
microRNA 149 |
656 |
0.43 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.8 | 10.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.6 | 6.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.6 | 6.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.5 | 7.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.4 | 4.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.4 | 2.8 | GO:0048880 | sensory system development(GO:0048880) |
1.4 | 4.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.3 | 3.9 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.3 | 2.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.3 | 15.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.3 | 2.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.2 | 3.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.2 | 3.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.2 | 10.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.1 | 4.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.1 | 11.3 | GO:0071625 | vocalization behavior(GO:0071625) |
1.1 | 3.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.1 | 10.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
1.1 | 4.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.0 | 2.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.0 | 6.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.0 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.9 | 4.7 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.9 | 2.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.9 | 0.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.9 | 4.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.9 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 2.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.9 | 3.5 | GO:0030091 | protein repair(GO:0030091) |
0.9 | 7.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 3.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.8 | 1.7 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.8 | 3.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 2.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.8 | 4.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.8 | 4.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 1.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.8 | 2.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.8 | 5.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 1.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.7 | 2.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.7 | 3.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.7 | 8.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.7 | 6.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 2.0 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.7 | 2.7 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.7 | 1.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.7 | 4.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 2.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.6 | 3.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 6.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.6 | 1.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 0.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 3.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 1.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.6 | 1.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.6 | 10.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.6 | 3.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.6 | 3.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.6 | 2.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.6 | 2.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.6 | 6.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.6 | 5.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.6 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 1.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.6 | 2.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.6 | 3.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 10.5 | GO:0001964 | startle response(GO:0001964) |
0.5 | 2.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.5 | 1.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.5 | 1.6 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.5 | 1.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.5 | 2.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 1.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 3.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 2.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 1.6 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.5 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 2.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 7.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.5 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 2.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.5 | 2.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 3.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.5 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 1.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.5 | 1.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 2.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 1.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 0.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.5 | 2.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 1.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.5 | 1.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 1.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.4 | 1.3 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 1.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 0.9 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.4 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 0.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 3.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 0.8 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.4 | 4.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.4 | 17.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 2.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 1.7 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 1.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.4 | 2.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.4 | 6.9 | GO:0060384 | innervation(GO:0060384) |
0.4 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 1.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 2.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 2.8 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 1.6 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.6 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 1.6 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.4 | 0.4 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.4 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.4 | 0.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 3.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 1.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 1.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 0.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 1.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 1.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 1.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.4 | 1.1 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 1.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.4 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 1.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 1.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.4 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 2.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.3 | 3.7 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.3 | 1.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 27.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 5.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 1.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 2.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 1.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 1.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.3 | 1.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 3.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 2.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.3 | GO:0010958 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.3 | 1.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.9 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 2.7 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.3 | 11.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 1.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 2.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 1.5 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.3 | 0.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 2.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 7.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 1.1 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.3 | 2.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 3.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 5.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 1.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 2.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 1.5 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.3 | 1.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 0.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 1.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.9 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.4 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 1.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 1.6 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 1.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 1.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.4 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.2 | 1.3 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.2 | 4.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 2.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.2 | GO:0046959 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.2 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 1.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 1.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.6 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 1.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 3.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 3.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.4 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.2 | GO:1901321 | positive regulation of heart induction(GO:1901321) |
0.2 | 0.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 1.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.2 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 1.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 1.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.2 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.2 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.7 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 0.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 1.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.4 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 1.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.2 | 0.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 1.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 1.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 0.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 1.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 0.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 1.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 5.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.5 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 4.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 3.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 1.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.2 | 0.6 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 2.1 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 0.3 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 1.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.4 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.8 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 2.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 1.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 4.2 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 1.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 2.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 1.0 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 4.4 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.4 | GO:0043379 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 1.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.7 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 2.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.4 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 0.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 1.5 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 3.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 1.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.9 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 1.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 1.0 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 1.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 0.6 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 1.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 1.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 2.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.4 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 1.3 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.1 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.7 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 1.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.5 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.4 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.8 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.1 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.1 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 1.4 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 1.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.6 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.1 | 0.8 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.7 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.6 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.5 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.1 | 0.2 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.6 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.2 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 1.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 1.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.1 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.2 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.5 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.6 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.5 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 1.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0060180 | female mating behavior(GO:0060180) |
0.1 | 1.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 1.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.2 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 1.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 1.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.3 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.0 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 1.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.3 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.1 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.6 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 7.2 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.0 | 0.6 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.1 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.3 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.0 | 0.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0072283 | metanephric renal vesicle morphogenesis(GO:0072283) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.0 | 0.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.2 | GO:0007618 | mating(GO:0007618) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.0 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.3 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.0 | 0.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.4 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.0 | 0.0 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.0 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 9.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.1 | 8.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 2.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 6.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 5.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 2.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 6.1 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 1.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 3.2 | GO:0097433 | dense body(GO:0097433) |
0.6 | 6.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 2.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 4.4 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 1.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.5 | 17.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 26.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 10.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 3.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 5.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 1.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 3.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 7.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 17.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 4.3 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 3.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 2.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 4.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 7.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 56.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 2.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 2.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.3 | GO:0005767 | secondary lysosome(GO:0005767) phagolysosome(GO:0032010) |
0.3 | 1.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 0.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 6.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.3 | 4.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 1.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.0 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 12.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.7 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 3.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 3.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 2.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 7.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.2 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.2 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.3 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 2.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 1.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 7.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 1.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 3.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 6.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.7 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 8.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 9.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 7.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 2.4 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 9.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 2.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 12.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 3.4 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 20.3 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 1.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 1.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 2.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 1.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 3.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 7.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.3 | 7.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.3 | 9.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.7 | 5.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.7 | 10.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.7 | 6.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.6 | 3.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.5 | 4.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.2 | 3.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.1 | 9.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.1 | 7.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 3.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 4.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 5.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.0 | 2.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.9 | 4.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 1.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 3.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.8 | 4.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 1.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 7.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 8.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 3.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 3.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.7 | 3.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.7 | 1.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 2.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.6 | 3.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 3.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 3.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.6 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 4.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 1.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 1.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 4.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 4.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 6.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 5.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 9.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 11.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 1.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 2.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 3.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 1.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 2.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 7.2 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 1.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 2.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 1.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 8.2 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 6.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 4.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 3.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 5.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 3.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 0.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.3 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 7.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 4.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 1.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 7.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 1.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 4.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 4.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 6.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 2.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 1.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 2.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 3.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 4.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 5.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 1.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 3.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 4.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 2.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 2.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 2.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 2.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 6.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 5.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 3.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 4.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 2.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 4.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 1.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 5.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.6 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.7 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 2.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 9.5 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 1.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.2 | GO:0034870 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 2.2 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 3.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 4.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.8 | GO:0034882 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 8.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.4 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 2.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0034955 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 14.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.6 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.2 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 16.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 5.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 4.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 5.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 5.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 10.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 6.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 3.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 3.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 8.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 7.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 9.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 3.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 14.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 16.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 18.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 6.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 19.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 7.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 8.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.4 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 8.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 4.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 3.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 5.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 3.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 5.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 3.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 3.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 5.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 1.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 6.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 3.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 3.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 9.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 9.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 3.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 4.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 2.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 1.6 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 2.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 3.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 4.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 6.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 14.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 4.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 2.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |